Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IPSEN (IPSEY : OTC)

• Company Description    Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. Number of Employees: 5,358

• Price / Volume Information    Yesterday's Closing Price: $48.76 Daily Weekly Monthly 20 Day Moving Average: 865 shares Shares Outstanding: 335.26 (millions) Market Capitalization: $16,347.18 (millions) Beta: 0.46 52 Week High: $51.10 52 Week Low: $28.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.57% -3.39% 12 Week 1.99% -5.72% Year To Date 34.10% 23.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 65 quai Georges Gorse - Boulogne-Billancourt cedex,I0 92100 FRA ph: 33-01-58-33-50-00 fax: 33-01-58-33-50-01 investor.relations@ipsen.com http://www.ipsen.com

• General Corporate Information    Officers David Loew - Chief Executive Officer Marc de Garidel - Chairman Aymeric Le Chatelier - Executive Vice-President; Chief Financial Officer Karen Witts - Director Carol Xueref - Director Peer Information IPSEN (GSAC) IPSEN (CASIF) IPSEN (ALCD.) IPSEN (OMNN) IPSEN (CGPI.) IPSEN (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 462629205 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 335.26 Most Recent Split Date: (:1) Beta: 0.46 Market Capitalization: $16,347.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.53% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.26 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.33 Price/Cash Flow: 8.85 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 1.96 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - 1.79 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - 14.73 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 14.64 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - 3.03 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©